Torbay Pharmaceuticals
Private Company
Funding information not available
Overview
Torbay Pharma is a specialized CDMO with a core focus on the contract manufacturing of terminally sterilized generic injectables, serving over 20 countries. Founded in 2008 and based in Paignton, UK, it operates as a private, revenue-generating service provider for pharmaceutical companies, emphasizing partnership over transactional relationships. The company leverages its expertise in sterile fill-finish and regulatory compliance to supply critical medicines to the secondary care/hospital sector, with additional capabilities in total parenteral nutrition (TPN) compounding and export services.
Technology Platform
Integrated CDMO services for terminally sterilized injectables, including technical assessment, sterile fill-finish, labeling/packaging, QP certification, and specialized TPN compounding.
Opportunities
Risk Factors
Competitive Landscape
Torbay Pharma competes in the fragmented but competitive CDMO market for sterile injectables. It faces competition from large, full-service global CDMOs (e.g., Viatris, Thermo Fisher/Catalent, Recipharm) and smaller regional specialists. Its differentiation lies in its focused expertise on terminal sterilization for generics, a partnership-oriented approach, and its authorization to handle both licensed and unlicensed products from a UK base.